New study aims to make biotherapy allergy testing safer for cancer patients

NCT ID NCT06971848

First seen Apr 09, 2026 · Last updated May 07, 2026 · Updated 4 times

Summary

This study looks at how to safely test for allergic reactions to biotherapy drugs in cancer patients. Researchers will test different concentrations of these drugs on the skin of 70 patients who have already received at least two doses without any allergic side effects. The goal is to find the highest concentration that does not cause a skin reaction, so doctors can better diagnose allergies in the future. This study does not offer a new treatment but will help improve safety for patients receiving biotherapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Angers

    Angers, 49933, France

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.